FDA Warns Amgen Over Vectibix Video
The US Food and Drug Administration warned Amgen that a promotional video for its colorectal cancer drug Vectibix was misleading. The agency stated the video highlighted benefits while failing to disclose serious safety risks and patient limitations.
Xurve View
Insights:
Xurve View
The United States FDA warned AMGEN INC that a promotional video for its colorectal cancer drug Vectibix was misleading, regulators said Tuesday morning. The warning highlights promotional materials that omitted critical safety risks and patient usage limitations for the treatment. The regulatory scrutiny poses compliance hurdles for the company's marketing strategy as health officials demand corrective communications.
